| Fund ID | 805-8161612565 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | No |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | No |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| Sales limited to qualified investors | No |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 0% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 100% |
| Fund | Type | Gross assets |
|---|---|---|
| Haddington Esp I LP | Private Equity | $674.1M |
| Hep Liquids LP | Private Equity | $35M |
| Haddington Energy Partners III LP | Private Equity | $14.2M |
Hep IV Aiv LP reports $300 in gross assets, among the top 100% of private funds by size.
The stated minimum investment is $5 million.
Hep IV Aiv LP is managed by Haddington Ventures, LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.